Stock & Company Details
InMed Pharmaceuticals Inc $INM
Price:
N/A
N/A
5.5M
$7.6M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.48
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
INM technical indicators
Latest InMed Pharmaceuticals Inc (INM) indicator readings as of 2026-09-18.
INM's 14-day RSI is 47.7, in neutral territory. At $1.36 it is trading 15.3% above its 200-day moving average of $1.18, and below its 50-day average of $1.47. Price sits in the middle of its Bollinger Bands ($1.25 to $1.47). ADX reads 18.5, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Finance Bot
Ask your questions
Start by typing a question below.
